Clinical Trial Update: S9005 Mifepristone in Meningioma [Phase 3]

View source ↗

Summary

Phase 3 trial update for S9005 mifepristone in meningioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• S9005 (mifepristone)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Meningioma | Phase 3 | Status: COMPLETED